-
Study Finds Climate Change Threatens Cacti More Than Previously Thought
-
New Bay of Bengal low may form November 13 as Tamil Nadu outlook remains unclear
-
एलेक्स बोडी और SCANDIC PAY: Mastercard और VISA कार्ड — भुगतान की नई पीढ़ी
-
ALEX BODI och SCANDIC PAY: Mastercard- och VISA-kort – en ny generation betalningar
-
АЛЕКС БОДИ и SCANDIC PAY: карти Mastercard и VISA — ново поколение разплащания
-
알렉스 보디와 SCANDIC PAY: Mastercard·VISA 카드를 통한 차세대 결제
-
أليكس بودي وSCANDIC PAY: بطاقات Mastercard وVISA — جيل جديد من المدفوعات
-
ALEX BODIとSCANDIC PAY:Mastercard・VISAカードによる新世代の決済
-
ALEX BODI 與 SCANDIC PAY:Mastercard 與 VISA 卡——新一代支付方式
-
ALEX BODI a SCANDIC PAY: karty Mastercard a VISA – nová generace plateb
-
ΑΛΕΞ ΜΠΟΝΤΙ και SCANDIC PAY: κάρτες Mastercard και VISA — μια νέα γενιά πληρωμών
-
ALEX BODI i SCANDIC PAY: karty Mastercard i VISA — nowa generacja płatności
-
АЛЕКС БОДІ та SCANDIC PAY: картки Mastercard і VISA — нове покоління платежів
-
АЛЕКС БОДИ и SCANDIC PAY: карты Mastercard и VISA — новое поколение платежей
-
ALEX BODI and SCANDIC PAY: Mastercard and VISA Cards – A New Generation of Payments
-
ALEX BODI și SCANDIC PAY: Cardurile Mastercard și VISA – o nouă generație de plăți
-
Maswanganyi Clarifies Pirates Allegiance Amidst Career Transition
-
Search Underway for 'Dooars Rani' Tigress After Second Escape from Buxa Tiger Reserve
-
Teatro Mayor Unveils 152-Performance 2027 Season Highlighting Beethoven and García Márquez
-
The Dilemma of Recording Live Music: Preserving Memories vs. Being Present
-
Rutgers Defeats NJIT 101-64 Behind Francis and Mark Scores
-
TAMKO and Kansas City Chiefs Announce 2026 Operation Rooftop Recipient
-
Ethur Takes On Hiring Fraud With Facial Biometrics Identity Checks and Connected Payroll and Bank Data
-
NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
-
Route1 Announces 2026 Annual Meeting Results
-
Healixa's FrostPulse(TM) Technology Solves a Major Roadblock to Data Center Growth: Cooling Without the Water Burden
-
Protagenic Therapeutics Announces Private Placement of Up to $5 Million to Advance PT00114 into Its First U.S. Clinical Trial in Generalized Anxiety Disorder
-
Patriot Software Adds Performance Reviews to Patriot HR
-
5E Advanced Materials to Host Fiscal First Quarter 2027 Earnings Conference Call on November 17, 2026
-
Marketing Worldwide Corporation (OTC:MWWC) Announces 1-for-350 Reverse Stock Split Effective November 11, 2026
-
Healthcare Leaders Identify Priorities for Agentic AI Adoption in 2027-2028 - Black Book
-
Aptevo Therapeutics Announces Exercise of Existing Warrants for $3.0 Million Gross Proceeds
-
Arrive AI Announces Strategic Investment in Ottonomy to Accelerate Autonomous Delivery Network Expansion
-
LiveOne (Nasdaq: LVO) to Report Second Quarter Fiscal 2027 Financial Results on November 12, 2026
-
Cosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million Annualized
-
OneMeta Provides Real-Time AI Translation for 2026 G20 Interfaith Forum Summit
-
6 Pieces of Furniture Worth Investing In
-
Cognitum One Launches Cognitum Spaces, the Governed System of Record for Physical Sites That Gives Enterprise AI Agents Trusted Real-World Context
-
PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
-
Green Leaf Innovations (OTC: GRLF) Meets OTCID Disclosure Requirements Following Profitable Q2 2026 Results
-
Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird's National Security Conference
-
XCF Global Hosts USDA at New Rise Renewables Reno as Facility Surpasses 4.4 Million Gallons Since Restart
-
Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
-
AmeriLife Welcomes Finance Veteran Richard Dziadzio as Chief Financial Officer; Names Jim Quinn President & Chief Transformation Officer
-
Trifecta Gold Reports 2026 Exploration Results from the Liam and Lois Projects, Tombstone Gold Belt, Yukon
-
Irving Resources Reports on Drilling in Yamagano Mining Right at the Yamagano Joint Venture, Kyushu, Japan
-
NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Christmas Day Shifts More than Double as Americans Return to In-Person Holiday Celebrations
-
THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
US family reaches deal over cells harvested in 1950s
A US biotechnology company has reached a settlement with the family of Henrietta Lacks, an African-American woman whose cells were used for groundbreaking medical research without her consent.
Civil rights attorney Ben Crump, who filed a lawsuit in 2021 on behalf of the Lacks' estate, announced on Tuesday that the family had agreed a confidential deal with Massachusetts-based firm Thermo Fisher Scientific.
"The parties are pleased that they were able to find a way to resolve this matter outside of court," Crump said, noting that Tuesday would have been Lacks' 103rd birthday.
Crump, who has represented the family of George Floyd and other Black victims of US police violence, said the settlement provides "some measure of justice for Henrietta Lacks, 70 years later."
The 31-year-old Lacks, a tobacco farmer from Virginia and mother of five, died of cervical cancer in 1951 at Johns Hopkins Hospital in Baltimore.
During attempts to cure her shortly before she died, Lacks' abnormally resilient cancer cells were removed from her tumor and were used for decades by researchers without her family's knowledge.
The cells, dubbed HeLa for the first letters of her first and last names, were the first-ever human cells to grow endlessly in the lab -- all others harvested up to that point died.
- Nobel Prizes -
Research using the cells led to Nobel Prize-winning discoveries, and laboratories worldwide used them to develop vaccines -- notably against polio -- as well as in cloning, in-vitro fertilization and many medicines, fueling an industry now worth billions of dollars.
The family knew nothing of Lacks' role until the 1970s, and only came to understand its full scope thanks to the work of Rebecca Skloot, author of the 2010 bestseller "The Immortal Life of Henrietta Lacks."
Lacks' story was also the subject of an HBO movie starring Oprah Winfrey.
"They treated her like a specimen, like a lab rat," her grand-daughter Kimberly Lacks said in 2021, describing the cell theft as racism.
Thermo Fisher Scientific confirmed the settlement, using the same language as the family lawyers Crump and Chris Seeger.
In filing the lawsuit in 2021, Seeger said that Thermo Fisher was the first of many companies that could face legal action for having "profited from the use" of the HeLa cells.
On its website, Johns Hopkins Hospital said that it has never sold or benefited from the discovery or distribution of HeLa cells, and does not own the rights to them.
"HeLa cells were offered freely and widely by Johns Hopkins for scientific research," it said.
"Johns Hopkins has worked in close coordination with several members of the Lacks family over the past decade to recognize and honor Henrietta Lacks, including scholarships, engagement with local schools and annual symposia," it added.
Y.Nakamura--AMWN